Resveratrol Supplementation Did Not Improve Cognition in Patients with Schizophrenia: Results from a Randomized Clinical Trial.

BACKGROUND: Schizophrenia (SZ) is associated with psychotic experiences and cognitive deficits. Therefore, cognitive function is one of the most critical determinants of quality of life in this pathology. Resveratrol has been related to neuroprotective action, but there are no studies evaluating resveratrol in SZ. The objective of this study was to determine the efficacy of resveratrol supplementation on cognition in individuals with SZ. METHODS: This is a 1-month randomized, double-blind, and controlled trial (NCT 02062190), in which 19 men with diagnosis of SZ, aged 18-65 years, were assigned to a resveratrol supplementation group (200 mg) or placebo group (200 mg), with a 1-month follow-up. Applying a series of cognitive tests assessed neuropsychology performance (Hopkins Verbal Learning Test, Stroop Color and Word Test, and Weschler Adult Intelligence Scale) and Brief Psychiatric Rating Scale assessed psychopathology severity. RESULTS: There were no significant improvement in neuropsychology performance (episodic memory, working memory, attention and concentration capacity, inhibitory control, interference measures, selective attention, and mental flexibility) and psychopathology severity after 1 month of resveratrol supplementation (P > 0.05). CONCLUSION: In conclusion, we have shown that 1 month of a resveratrol supplementation (200 mg/day) did not improve episodic memory, working memory, attention and concentration capacity, inhibitory control, interference measures, selective attention, and mental flexibility as compared with placebo in patients with SZ.

Resveratrol Supplementation in Schizophrenia Patients: A Randomized Clinical Trial Evaluating Serum Glucose and Cardiovascular Risk Factors.

BACKGROUND: Patients with schizophrenia (SZ) are generally overweight or obese and have several metabolic disorders. Additionally, such patients have a lower life expectancy and the main cause of their increased mortality is cardiovascular disease (CVD). The objective of this study was to determine the efficacy of resveratrol supplementation on serum glucose and CVD risk factors in individuals with SZ. METHODS AND RESULTS: This is a four-week randomized, double-blind controlled trial (registration No.: NCT 02062190) in which 19 men with a diagnosis of SZ, aged 18 to 65, were assigned to either a resveratrol supplement group (200 mg/day) or a placebo group (200 mg/day). In short, we did not observe significant changes after resveratrol supplementation. In the placebo group, we found a significant increase in total cholesterol levels (p = 0.024) and in LDL-cholesterol (p = 0.002), as well as a decrease in body fat percentage (p = 0.038). The placebo group also showed an increase in triglycerides (9.19%) and a reduction in HDL-cholesterol (4.88%). In the resveratrol group, triglycerides decreased (7.64%). CONCLUSION: In summary, oral resveratrol in reasonably low dosages (200 mg daily) brought no differences to body weight, waist circumference, glucose, and total cholesterol. It was possible to note that the lipid profile in the placebo group worsened and, although no significant differences were found, we can assume that resveratrol might prevent lipid profile damage and that the intervention affected the lipoprotein metabolism at various levels.

Avaliação do consumo alimentar de crianças pertencentes a uma creche filantrópica na Ilha de Paquetá, Rio de Janeiro, Brasil / Food intake assessment of children attending a philanthropic daycare center in the Ilha de Paquetá, Rio de Janeiro, Brazil

OBJETIVOS: comparar o consumo alimentar de pré-escolares, pertencentes a uma creche filantrópica, em dois períodos (no ato da matrícula e após seis meses), com base na proposta da Pirâmide Alimentar Infantil Norte-Americana e através do índice de Alimentação Saudável (IAS). MÉTODOS: relativamente à avaliação dietética, foi utilizada a história alimentar da criança com o responsável, no ato da matrícula; após seis meses de frequência da criança, utilizou-se o método de pesagem de alimentos (na creche) e registro alimentar (na residência). Posteriormente, compararam-se as médias das porções consumidas nos dois períodos, de cada grupo alimentar, utilizando o teste "t" Student, a fim de se verificar a diferença estatística entre os grupos. Considerou-se o nível de significância de 5 por cento. Igualmente, avaliou-se o IAS, nos dois períodos. RESULTADOS: observou-se uma diferença significativa (p<0,05) entre a média das porções de frutas e vegetais, com base na Pirâmide Alimentar Americana, e um escore satisfatório do índice de Alimentação Saudável, após seis meses de frequência da criança na creche. CONCLUSÕES: a freqüência à creche parece trazer benefícios para a nutrição de crianças pertencentes à estratos socioeconômicos menos favorecidos.